Article
Fabry disease.
Pharmacology & therapeutics - 1 Apr 2009
Schiffmann Raphael
Abstract excerpt
Fabry disease, an X-linked disorder of glycosphingolipids that is caused by the deficiency of alpha-galactosidase A, is associated with dysfunction of many cell types and includes a systemic vasculopathy. As a result, patients have a markedly increased risk of developing small-fiber peripheral neuropathy, stroke, myriad cardiac manifestations and chronic renal disease. Virtually all complications of Fabry disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
